EyePoint Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • EyePoint Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$34.5M, a 51.8% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$98.6M, a 7.36% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$75.1M, a 24.7% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$99.6M, a 80.3% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$55.3M, a 48.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$75.1M +$24.6M +24.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 -$99.6M -$44.4M -80.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 -$55.3M -$18M -48.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 -$37.3M +$10.6M +22.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 -$47.9M -$8.84M -22.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$39M -$20.4M -110% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$18.6M +$3.2M +14.7% Jul 1, 2016 Jun 30, 2017 10-K 2020-03-16
2016 -$21.8M -$28.2M -439% Jul 1, 2015 Jun 30, 2016 10-KT 2019-03-18
2015 $6.42M +$19.9M Jul 1, 2014 Jun 30, 2015 10-K 2017-09-13
2014 -$13.5M -$1.46M -12.1% Jul 1, 2013 Jun 30, 2014 10-K 2016-09-13
2013 -$12M +$13.2M +52.3% Jul 1, 2012 Jun 30, 2013 10-K 2015-09-10
2012 -$25.2M -$15.2M -152% Jul 1, 2011 Jun 30, 2012 10-K 2014-09-11
2011 -$10M -$19.1M -210% Jul 1, 2010 Jun 30, 2011 10-K 2013-09-27
2010 $9.09M Jul 1, 2009 Jun 30, 2010 10-K 2012-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.